Stanley Druckenmiller and Nvidia Just Piled Into This Obscure Startup

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend - twice featured on 60 Minutes - predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Regeneron Pharmaceuticals, Inc
NASDAQ:REGN
$560.00

Financials

Curr Year EPS Estimate39.37
Next Quarter EPS Estimate9.15
Profit Margin31.37%
Operating Margin27.83
Return on Assets0.07
Return on Equity0.15
Revenue14.2B
Earnings Per Share39.70
Revenue Per Share133.03
Gross Profit6,730,500,096
Quarterly Revenue Growth0.04

General

NameRegeneron Pharmaceuticals, Inc
TickerREGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees15,182

About Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Dividend

Regeneron Pharmaceuticals, Inc pays out a dividend of $2.98 per share, with a dividend yield of 0.53%.

REGN's last dividend payment was made to shareholders on September 3, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Sep 3, 2025$0.88
Jun 6, 2025$0.88
Mar 20, 2025$0.88
Popular

Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report

Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

Could You Use Some Instant Cash Upfront? - Ad

Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.

Qualcomm And Valeo Broaden Collaboration To Speed Hands Off Driving Features

Qualcomm and Valeo partner to launch ADAS and AD solutions, integrating Snapdragon Ride SoC and software stack with Valeo's sensors and systems.

Nvidia CEO Makes First Ever Tesla Announcement - Ad

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

Why GameStop Shares Are Spiking After-Hours

GameStop Corp. (NYSE:GME) shares surged 5.72% during after-hours trading to $24.94 following strong second-quarter earnings and a special dividend announcemen

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Macron Warns World Will Know By Monday If Putin 'Played' Trump Again

French President Emmanuel Macron has voiced apprehensions about Vladimir Putin potentially manipulating President Trump.

Jim Cramer Recommends Buying This Industrial Stock, Calling It 'Way Too Cheap'

"Mad Money" star Jim Cramer discusses MP Materials, Resideo Technologies and Canadian National Railway on Friday, Sept. 12.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.

California crew arrested for hundreds of Home Depot thefts worth $10M, police say

VENTURA COUNTY, Calif. (AP) — Southern California authorities say they uncovered a criminal ring that stole $10 million in merchandise from Home Depot over several years, including 600 thefts this year alone, which the company calls the largest organized retail theft in its history.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Bitcoin, Dogecoin, XRP Gain; Ethereum Trades Flat: Analyst Predicts ETH Reversal Before Q4 Parabolic Rally

Leading cryptocurrencies rose in tandem with stocks on Monday, as investors increased their risk appetite ahead of key inflation data reports.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Backpage executives to be sentenced after testifying against site founder about the site's sex ads

PHOENIX (AP) — Two former executives for the Backpage.com are scheduled to be sentenced Tuesday in Phoenix for conspiring to facilitate prostitution by selling sex ads.

Mortgage Fraud Is Now A Trump-Era Flashpoint—Here's Everything You Need To Know

Given the recent high-profile cases, Benzinga decided to take a closer look at what mortgage fraud is and how it can be committed.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the October 1st funding window closes.

Third Richest Woman In The World Eyes New York Giants Stake For Future Growth

One of the richest women in the world could have her eyes on more sports team ownership with a stake in the New York Giants.

The New Way to Use AI in the Stock Market... - Ad

A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.

What's Happening With Regeneron Pharmaceuticals Stock On Monday?

Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the way for future development.

Epstein accuser Virginia Giuffre wrote a memoir. Months after her death, it's coming out

NEW YORK (AP) — A posthumous and “unsparing” memoir by one of most prominent accusers, will be published this fall, publishing house Alfred A. Knopf said Sunday.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Powerball jackpot rises to an estimated $1.3 billion after no winning ticket sold

DES MOINES, Iowa (AP) — The Powerball jackpot rose to an estimated $1.3 billion Monday night after the winning numbers failed to appear.

Stanley Druckenmiller and Nvidia Just Piled Into This Obscure Startup - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend - twice featured on 60 Minutes - predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost

On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) totaling $2.1 million. This follows Tempus AI's recent acquisition and mixed analyst ratings. Other key trades include purchases of Prime Medicine Inc (PRME) and Twist Bioscience Corp (TWST).

Super Micro Computer (SMCI) Shares Are Sliding Tuesday: What's Going On?

Super Micro Computer shares are trading lower Tuesday. The stock is caught in a downdraft affecting the broader semiconductor and high-growth technology sectors.

Could You Use Some Instant Cash Upfront? - Ad

Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.

Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post

WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.

Bitcoin Will Correct Further In September, Analyst Maintains

Prominent crypto analyst Benjamin Cowen has emphasized his expectation of a September pullback for Bitcoin (CRYPTO: BTC), highlighting critical support levels to watch.

Nvidia CEO Makes First Ever Tesla Announcement - Ad

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

Trump fires Fed Governor Lisa Cook, opening new front in fight for control over central bank

WASHINGTON (AP) — President Donald Trump fired late Monday, a surprise move constituting a sharp escalation in his battle to exert greater control over what has long been considered an institution .

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Jim Cramer: Sell Chime, Get This Buy Now Pay Later Stock Instead

Chime Financial, on Aug. 22, announced a strategic partnership with Workday to advance financial wellness in the workplace.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service